COVID-specific T's may offset therapeutically endangered B's
- PMID: 34989773
- PMCID: PMC8734939
- DOI: 10.1182/blood.2021014466
COVID-specific T's may offset therapeutically endangered B's
Figures

Comment on
-
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma.Blood. 2022 Jan 6;139(1):137-142. doi: 10.1182/blood.2021013429. Blood. 2022. PMID: 34657156 Free PMC article. No abstract available.
-
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients.Blood. 2022 Jan 6;139(1):142-147. doi: 10.1182/blood.2021013445. Blood. 2022. PMID: 34669919 Free PMC article. No abstract available.
References
-
- Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572–577. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources